Literature DB >> 27875105

Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation.

Aaron W P Maxwell1, Grayson L Baird1, Jason D Iannuccilli1, William W Mayo-Smith1, Damian E Dupuy1.   

Abstract

Purpose To evaluate the performance of the radius, exophytic or endophytic, nearness to collecting system or sinus, anterior or posterior, and location relative to polar lines (RENAL) nephrometry and preoperative aspects and dimensions used for anatomic classification (PADUA) scoring systems and other tumor biometrics for prediction of local tumor recurrence in patients with renal cell carcinoma after thermal ablation. Materials and Methods This HIPAA-compliant study was performed with a waiver of informed consent after institutional review board approval was obtained. A retrospective evaluation of 207 consecutive patients (131 men, 76 women; mean age, 71.9 years ± 10.9) with 217 biopsy-proven renal cell carcinoma tumors treated with thermal ablation was conducted. Serial postablation computed tomography (CT) or magnetic resonance (MR) imaging was used to evaluate for local tumor recurrence. For each tumor, RENAL nephrometry and PADUA scores were calculated by using imaging-derived tumor morphologic data. Several additional tumor biometrics and combinations thereof were also measured, including maximum tumor diameter. The Harrell C index and hazard regression techniques were used to quantify associations with local tumor recurrence. Results The RENAL (hazard ratio, 1.43; P = .003) and PADUA (hazard ratio, 1.80; P < .0001) scores were found to be significantly associated with recurrence when regression techniques were used but demonstrated only poor to fair discrimination according to Harrell C index results (C, 0.68 and 0.75, respectively). Maximum tumor diameter showed the highest discriminatory strength of any individual variable evaluated (C, 0.81) and was also significantly predictive when regression techniques were used (hazard ratio, 2.98; P < .0001). For every 1-cm increase in diameter, the estimated rate of recurrence risk increased by 198%. Conclusion Maximum tumor diameter demonstrates superior performance relative to existing tumor scoring systems and other evaluated biometrics for prediction of local tumor recurrence after renal cell carcinoma ablation. © RSNA, 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27875105     DOI: 10.1148/radiol.2016161225

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

Review 1.  Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.

Authors:  Serge Ginzburg; Jeffrey J Tomaszewski; Alexander Kutikov
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

2.  A simplified new-generation renal mass complexity scoring system.

Authors:  Ali Hajiran; Ahmet M Aydin; Salim K Cheriyan; Wade J Sexton
Journal:  Ann Transl Med       Date:  2019-09

Review 3.  Renal Cell Carcinoma Ablation: Preprocedural, Intraprocedural, and Postprocedural Imaging.

Authors:  Winston B Joe; Jessica G Zarzour; Andrew J Gunn
Journal:  Radiol Imaging Cancer       Date:  2019-11-29

Review 4.  Systematic Review of Contemporary Evidence for the Management of T1 Renal Cell Carcinoma: What IRs Need to Know for Kidney Cancer Tumor Boards.

Authors:  Julie Cronan; Sean Dariushnia; Zachary Bercu; Robert Mitchell Ermentrout; Bill Majdalany; Laura Findeiss; Janice Newsome; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

5.  Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical Outcomes.

Authors:  Andrew J Gunn; Winston B Joe; Aliaksei Salei; Husameddin El Khudari; Khalid H Mahmoud; Eric Bready; Eric M Keasler; Patrick P Patten; Jennifer B Gordetsky; Soroush Rais-Bahrami; Ahmed K Abdel Aal
Journal:  Cardiovasc Intervent Radiol       Date:  2019-05-01       Impact factor: 2.740

6.  Association among the R.E.N.A.L. nephrometry score and clinical outcomes in patients with small renal masses treated with percutaneous contrast enhanced ultrasound radiofrequency ablation.

Authors:  Cristian Konstantinidis; Enrique Trilla; Xavier Serres; Carolina Montealegre; David Lorente; Rafael Castellón; Juan Morote
Journal:  Cent European J Urol       Date:  2019-06-04

7.  The effectiveness of RENAL nephrometry score in ablated renal tumors via radiofrequency ablation or cryoablation

Authors:  Seda Aladağ Kurt; Cem Yücel; Suna Özhan Oktar; Gonca Erbaş; Sinan Sözen; Ali Yusuf Öner
Journal:  Turk J Med Sci       Date:  2019-06-18       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.